Seeking Alpha

Spinal implant maker NuVasive (NUVA +17%) pops after its Q1 results easily beat estimates,...

Spinal implant maker NuVasive (NUVA +17%) pops after its Q1 results easily beat estimates, coming in at the high end of the expected range. Revenue jumped 21% Y/Y on strong sales of its minimally invasive spinal surgery products. William Blair and Baird both upgrade the stock on the back of the better than expected results.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|